ARCHIVES

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

June 7, 2002

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

Federal Cigarettes Tax Extension Approved By Senate

October 4, 1985

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013